Edgar Jost
- Hematology top 2%
- Acute Myeloid Leukemia Research 33
- Chronic Myeloid Leukemia Treatments 14
- Hematopoietic Stem Cell Transplantation 10
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Chronic Lymphocytic Leukemia Research 10
- Immunology top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 21
- Cancer-related gene regulation 8
- Oncology top 10%
-
- Acute Lymphoblastic Leukemia research 10
- Co-authors
- Stefan WilopR. OsiekaOliver GalmJames G. HermanMartina CrysandtStefan BarthEdgar DahlGerald Gehbauer
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Edgar Jost
97 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 96
- Hematology 551
- Genetics 318
- Immunology 314
- Molecular Biology 1.0k
- Oncology 392
Countries citing papers authored by Edgar Jost
This map shows the geographic impact of Edgar Jost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Jost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Jost more than expected).
Fields of papers citing papers by Edgar Jost
This network shows the impact of papers produced by Edgar Jost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Jost. The network helps show where Edgar Jost may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edgar Jost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2021 | 1 | |
| 6 | 2017 | 2 | |
| 7 | 2017 | 4 | |
| 8 | 2017 | 0 | |
| 9 | 2016 | 5 | |
| 10 | 2016 | 21 | |
| 11 | 2015 | 18 | |
| 12 | 2012 | 60 | |
| 13 | 2011 | 33 | |
| 14 | 2009 | 39 | |
| 15 | 2009 | 9 | |
| 16 | 2008 | 54 | |
| 17 | 2008 | 39 | |
| 18 | 2005 | 71 | |
| 19 | 2003 | 3 | |
| 20 | 2001 | 3 |
About Edgar Jost
Edgar Jost is a scholar working on Hematology, Genetics and Immunology, having authored 100 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (33 papers), Epigenetics and DNA Methylation (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (10 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Hematology (551 citations), Genetics (318 citations) and Immunology (314 citations). Edgar Jost has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Stefan Wilop, R. Osieka, Oliver Galm, James G. Herman, Martina Crysandt, Stefan Barth, Edgar Dahl, Gerald Gehbauer, Tim H. Brümmendorf and Tim H. Brümmendorf. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Clinical Epigenetics and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.